 STONY BROOK, N.Y.--BUSINESS WIRE--- APDN COVID19--Applied DNA Sciences, Inc. NASDAQ: APDN Applied DNA or the Company, a leader in Polymerase Chain Reaction PCR-based DNA manufacturing, today announced consolidated financial results for the full fiscal year and quarter ended September 30, 2020. Our activities in fiscal 2020 were principally devoted to the establishment of our diagnostic and surveillance testing programs for COVID-19 and to further positioning our proprietary LinearDNATM manufacturin 